Cardiovascular Systems Inc (CSII) Shares Bought by First Light Asset Management LLC

First Light Asset Management LLC raised its holdings in Cardiovascular Systems Inc (NASDAQ:CSII) by 5.8% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 469,687 shares of the medical device company’s stock after buying an additional 25,683 shares during the period. Cardiovascular Systems comprises approximately 2.3% of First Light Asset Management LLC’s investment portfolio, making the stock its 15th biggest holding. First Light Asset Management LLC owned approximately 1.41% of Cardiovascular Systems worth $10,300,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Brown Capital Management LLC raised its stake in Cardiovascular Systems by 7.0% in the fourth quarter. Brown Capital Management LLC now owns 2,659,509 shares of the medical device company’s stock valued at $63,004,000 after buying an additional 173,271 shares during the period. Renaissance Technologies LLC grew its position in shares of Cardiovascular Systems by 69.7% in the fourth quarter. Renaissance Technologies LLC now owns 899,300 shares of the medical device company’s stock valued at $21,304,000 after purchasing an additional 369,500 shares during the last quarter. Bank of Montreal Can grew its position in shares of Cardiovascular Systems by 12.5% in the fourth quarter. Bank of Montreal Can now owns 53,889 shares of the medical device company’s stock valued at $1,277,000 after purchasing an additional 5,998 shares during the last quarter. Teacher Retirement System of Texas acquired a new position in shares of Cardiovascular Systems in the fourth quarter valued at approximately $273,000. Finally, Champlain Investment Partners LLC grew its position in shares of Cardiovascular Systems by 21.3% in the fourth quarter. Champlain Investment Partners LLC now owns 2,253,355 shares of the medical device company’s stock valued at $53,382,000 after purchasing an additional 396,145 shares during the last quarter. Hedge funds and other institutional investors own 81.08% of the company’s stock.

Cardiovascular Systems stock opened at $31.20 on Thursday. Cardiovascular Systems Inc has a 12 month low of $20.58 and a 12 month high of $33.11. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.99 and a current ratio of 4.46. The company has a market capitalization of $993.42 million, a PE ratio of 1,040.00 and a beta of 2.21.

Cardiovascular Systems (NASDAQ:CSII) last posted its earnings results on Wednesday, May 2nd. The medical device company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.03. Cardiovascular Systems had a negative return on equity of 1.03% and a negative net margin of 0.59%. The company had revenue of $55.59 million for the quarter, compared to the consensus estimate of $55.63 million.

Several research firms have recently commented on CSII. BidaskClub raised Cardiovascular Systems from a “hold” rating to a “buy” rating in a research report on Friday, May 18th. ValuEngine raised Cardiovascular Systems from a “sell” rating to a “hold” rating in a research report on Wednesday, May 16th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cardiovascular Systems in a research report on Thursday, May 3rd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $27.00.

Cardiovascular Systems Profile

Cardiovascular Systems, Inc, a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives.

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit